Medroxyprogesterone Acetate Antikörper
Dieses Anti-Medroxyprogesterone Acetate-Antikörper ist ein Schaf Polyklonal-Antikörper zur Detektion von Medroxyprogesterone Acetate in EIA. Geeignet für .
Produktnummer ABIN487732
Kurzübersicht für Medroxyprogesterone Acetate Antikörper (ABIN487732)
Target
Medroxyprogesterone Acetate
Reaktivität
Bitte anfragen
Wirt
Schaf
Klonalität
Polyklonal
Konjugat
Dieser Medroxyprogesterone Acetate Antikörper ist unkonjugiert
Applikation
Enzyme Immunoassay (EIA)
-
-
Aufreinigung
- Ig Fraction
-
Immunogen
- Medroxyprogesterone acetate (3)-BTG
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA: 0.1 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 9.70mg/mL (U.V. abs at 280nm)
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
-
- Medroxyprogesterone Acetate
-
Substanzklasse
- Chemical
-
Hintergrund
- MPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30?% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.Synonyms: MPA, Medroxy Progesterone Acetate, depo provera
Target
-
Sie sind hier:
